Get back into the swing of things with blog posts from The Freedonia Group, Simba Information, Freedonia Focus Reports, and Kalorama Information. In addition to market analysis, this week’s round-up includes observations on the state of market research from our CEO and Founder Rob Granader.
CEO Rob Granader Weighs in on MarketResearch.com’s History and Future
MarketResearch.com, the leading research aggregator and parent company of Profound, The Freedonia Group, Packaged Facts and Simba Information, celebrates its 20th year in business.
2 Key Ways Commercial Construction Spending to Drive Commercial Roofing Demand
Above average storm activity led to an above rise in commercial roofing sales in 2017. As storm-related growth moderates, find out which commercial roofing market segments are expected to post the highest gains going forward.
Syama: The Mine of the Future
Resolute’s Syama gold mine in Mali is expected to become the world’s first fully automated mine by the end of this year. How will automation impact the global mining equipment industry going forward?
Elections Lead to Changes in State Boards of Education Members and Agenda Issues
To learn more about how policy and funding impacts the educational publishing market, consult "Publishing for PreK-12 Market 2018-2019", a report from Simba Information.
Turning the Tables on the Furniture Industry
The furniture industry – which has historically operated on a single business model – is experiencing disruption from challengers leveraging new strategies to attract new customers.
Kalorama To Present IVD Market Findings at BIOMEDevice
Kalorama Information will present findings on direct to consumer testing, point of care, novel biomarkers, wearables, AI and robotics, new EU regulations, and more at December’s BIOMEDevice meeting in San Jose, CA.
5 Key Ways We Help Clients Evaluate a Publisher or Report
Robert Kaminsky navigates the top five ways Marketresearch.com’s specialists can help clients make informed decisions about their syndicated research needs.
China Biopharma Growth Exceeding Western Projections
The Chinese biopharmaceutical industry is growing more quickly than many Western companies anticipated. Where are opportunities for global biopharma and biotech firms to capitalize on this growth going forward?
